<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00771940</url>
  </required_header>
  <id_info>
    <org_study_id>M-2007008</org_study_id>
    <nct_id>NCT00771940</nct_id>
  </id_info>
  <brief_title>Peripheral Metabolic Effects of Ghrelin</brief_title>
  <official_title>Peripheral Metabolic Effects of Intra Arterial Ghrelin Infusion in Healthy Controls</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate putative peripheral effects of ghrelin on glucose and
      lipid metabolism in healthy men. Eight subjects will be enrolled. The hypothesis is that
      ghrelin infusion causes insulin resistance and lipolysis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma levels of glucose</measure>
    <time_frame>During study day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin signaling</measure>
    <time_frame>Study day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum levels of fatty acids</measure>
    <time_frame>Study day</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">8</enrollment>
  <condition>Healthy Controls</condition>
  <arm_group>
    <arm_group_label>Ghrelin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ghrelin</intervention_name>
    <description>Solvent, cont. infusion</description>
    <arm_group_label>Ghrelin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. BMI &lt; 27 kg/m2

          2. Written informed consent

          3. Non-smoker

        Exclusion Criteria:

          1. Any disease including epilepsy

          2. Any use of medications (excl. paracetamol)

          3. Present or previous malignancy

          4. Alcohol dependency

          5. Allergy to any trial medication
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens Otto L. Jorgensen, MD</last_name>
    <role>Study Director</role>
    <affiliation>Medical Department M, Aarhus University Horpital, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Esben T Vestergaard, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Department M, Aarhus University Hospital, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>Dk-8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 8, 2008</study_first_submitted>
  <study_first_submitted_qc>October 13, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2008</study_first_posted>
  <last_update_submitted>February 2, 2009</last_update_submitted>
  <last_update_submitted_qc>February 2, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2009</last_update_posted>
  <responsible_party>
    <name_title>Jens Otto Lunde Jorgensen/MD Professor and Esben T. Vestergaard/MD PhD</name_title>
    <organization>Aarhus University Hospital</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

